Source: Eur Respir Monogr 2019; 85: 114-126



Rating:

Share or cite this content

Citations should be made in the following way:
Pavel Strnad, Carolin V. Schneider, Virginia Clark. Clinical approach to liver disease in adults with AATD. Eur Respir Monogr 2019; 85: 114-126

Member's Comments

No comment yet.

Related content which might interest you: Clinical approach to paediatric liver disease Source: Eur Respir Monogr 2019; 85: 105-113 Year: 2019 Treatment of lung disease in patients with AATD Source: Eur Respir Monogr 2019; 85: 78-92 Year: 2019 Mechanisms of liver disease in AATD Source: Eur Respir Monogr 2019; 85: 93-104 Year: 2019 Clinical approach to the diagnosis and assessment of AATD Source: Eur Respir Monogr 2019; 85: 64-77 Year: 2019 Laboratory testing of individuals with severe α1-antitrypsin deficiency in three European centres Source: Eur Respir J 2010; 35: 960-968 Year: 2010 Mechanisms of lung disease in AATD Source: Eur Respir Monogr 2019; 85: 52-63 Year: 2019 Study of lung functions in patients of chronic liver disease. Source: International Congress 2017 – Miscellaneous clinical problems Year: 2017 Epidemiologic basis for differential diagnosis of obstructive lung disease in adults Source: Eur Respir J 2003; 22: Suppl. 45, 66s Year: 2003 Differences of disease phenotypes in individuals with alpha-1-antitrypsin deficiency with genotypes PiZZ and PiSZ - Analysis from the German registry Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Prevalence of chronic kidney disease (CKD) in the UK COPD population Source: International Congress 2014 – COPD exacerbations Year: 2014 Screening of chronic liver disease by transient elastography in patients with lung disease associated with alpha-1 antitrypsin deficiency. Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Study of IPF relatives as a method of early diagnosis of ILD disease Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Results of a case-detection programme for α1-antitrypsin deficiency in COPD patients Source: Eur Respir J 2005; 26: 616-622 Year: 2005 Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011 Osteoporosis in end-stage lung disease Source: Eur Respir Mon; 2009: 45: 62–78 Year: 2009 Clinical study of pediatric interstitial lung diseases in China Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Prevalence of acute liver dysfunction and chronic liver disease in an Irish adult cystic fibrosis population Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Long-term evolution of individuals with alpha1 antitrypsin deficiency from the Spanish registry Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases Year: 2015 European screening for α1-antitrypsin deficiency in subjects with lung disease Source: Annual Congress 2011 - Respiratory epidemiology: genetics and modifiable risk factors Year: 2011